Latest Ratings for AGCO Date Firm Action From To Mar 2022 Wells Fargo Initiates Coverage On Overweight Feb 2022 Morgan Stanley Maintains Overweight Jan 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for AGCO View the Latest Analyst Ratings read more
Latest Ratings for TRNO Date Firm Action From To Jan 2022 Baird Downgrades Outperform Neutral Dec 2021 BTIG Maintains Buy Nov 2021 Keybanc Maintains Overweight View More Analyst Ratings for TRNO View the Latest Analyst Ratings read more
Latest Ratings for TITN Date Firm Action From To Nov 2021 Craig-Hallum Maintains Buy Nov 2021 Baird Downgrades Outperform Neutral May 2021 Stephens & Co. Upgrades Equal-Weight Overweight View More Analyst Ratings for TITN View the Latest Analyst Ratings read more
Hologic declined a $16 billion buyout bid from TPG and Blackstone as it faces falling shares and tariff-related headwinds, leaving room for deal talks to potentially resume. read more
Cryptocurrency markets are up on Tuesday amid reports of Trump Media Group pursuing a Bitcoin acquisition strategy. read more
Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design. read more
HC Wainwright upgrades Kyverna to Buy with a $5 target, citing upcoming trial data and a strong cash position that supports a runway into 2027. read more
Analyst views e.l.f.’s $1 price hike as tariff-resilient move, eyes China strategy update in Q4 earnings. Latest Ratings for ELF Date Firm Action From To Feb 2022 DA Davidson Maintains Buy Jan 2022 Raymond James Maintains Outperform Nov 2021 DA Davidson Maintains Buy View More Analyst Ratings for ELF View the Latest Analyst Ratings read…